Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Medical Devices

STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in procedure rooms, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument, devices, and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The AST segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of contract sterilization and laboratory facilities, as well as integrated sterilization equipment and control systems to medical device manufacturers and research institutions. The Life Sciences segment designs, manufactures, and sells consumable products, such as pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. It serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is headquartered in Mentor, Ohio.

Revenue projections:

Revenue projections for STE
Revenue projections for STE

The projected decline in STE's revenues compared to last year is expected to make investors cautious. A drop in revenue often has a direct negative effect on the company's bottom line, signaling potential challenges that could undermine investor confidence and reduce overall profitability.

Financial Ratios:

currentRatio 2.479000
forwardPE 19.352364
debtToEquity 28.651000
earningsGrowth 0.121000
revenueGrowth 0.092000
grossMargins 0.443220
operatingMargins 0.184940
trailingEps 7.160000
forwardEps 11.078750

STE's current ratio of 2.479 shows that the company has ample resources to service its short-term debt. This indicates a solid financial position, as STE can rely on its cash reserves and current assets to cover its immediate liabilities without strain.
STE's Forward PE ratio is favorable, meaning the stock price aligns well with earnings and isn't overvalued. This allows room for growth, making it an attractive investment for those seeking potential upside while ensuring the stock is not overpriced.
STE's low Debt-to-Equity ratio indicates the company is not over-leveraged. This suggests a balanced financial structure with limited reliance on debt, which reduces financial risk and enhances its stability, making STE's financial position more secure and appealing to investors.
STERIS plc's forward EPS is higher than its trailing EPS, suggesting the company is expected to improve its profitability this financial year. This reflects growing confidence in STERIS plc's earnings potential, with forecasts indicating better financial performance than in the prior year.

Price projections:

Price projections for STE
Price projections for STE

The price of STE currently does not indicate any clear risks or opportunities when compared to projections. This balanced stance suggests that investors may prefer to hold off on major decisions until new information arises.

Insider Transactions:

Insider Transactions for STE
Insider Transactions for STE


There were 10 transactions selling STERIS plc stock, with prevailing market price of 249.27000122070314.No sell transactions took place in the period under consideration.STE is seeing more buys than sells at current price levels, which may indicate a positive market outlook. This trend suggests growing confidence among investors, who appear to expect favorable performance from the stock.

Recommendation changes over time:

Recommendations trend for STE
Recommendations trend for STE


STERIS plc has been receiving a buy bias from analysts, signaling strong confidence in the stock's future performance. This positive outlook might drive investors to view STERIS plc as an attractive option for their portfolios, positioning the company as a stable and profitable investment choice.